This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
General Electric, 1984 (Spanish Version)
Aguilar, Francis J.; Hamermesh, Richard G.; Brainard, Caroline E.Case HBS-302S36Knowledge and CommunicationDescribe los primeros cuatro años de permanencia de Jack Welch como CEO de las ofertas de General Electric Co. con las formas Welch ha tratado de actividades de estrategia y planificación del cambio de GE y sus intentos de hacer la empresa más empresarial.Starting at €8.20
-
Foro Energy (B)
Lassiter, Joseph B.; Sahlman, William A.; McQuade, JamesCase HBS-812163-EEntrepreneurshipForo Energy developed proprietary and patent-pending fiber-laser technologies that could disrupt existing processes and services for the exploration and production of oil and natural gas. These breakthrough laser technologies were protected by a strong intellectual property (IP) portfolio, which provided Foro with the flexibility to pursue a number of different business models. The market potential for oilfield applications was large, as global s...Starting at €5.74
-
Foro Energy (A)
Lassiter, Joseph B.; Sahlman, William A.; McQuade, JamesCase HBS-812136-EEntrepreneurshipForo Energy developed proprietary and patent-pending fiber-laser technologies that could disrupt existing processes and services for the exploration and production of oil and natural gas. These breakthrough laser technologies were protected by a strong intellectual property (IP) portfolio, which provided Foro with the flexibility to pursue a number of different business models. The market potential for oilfield applications was large, as global s...Starting at €8.20
-
U.S. Department of Energy & Recovery Act Funding: Bridging the "Valley of Death"
Roberts, Michael J.; Lassiter, Joseph B.; Nanda, RamanaCase HBS-810144-EEntrepreneurshipThe case focuses on the US Dept. of Energy and the $38 billion dollars of stimulus funding the DOE received to encourage clean tech. They focus on "bridging the valley of death" i.e., helping young, innovative companies finance technically risky and very capital intensive development and commercialization programs. The case focuses on two DOE programs in particular, the Loan Guarantee Program and ARPA-E. The case raises the question of why these ...Starting at €8.20
-
InPart (Spanish version)
Lassiter, Joseph B.; Roberts, Michael J.; Biotti, Jon M.Case HBS-815S15EntrepreneurshipStacey Lawson, HBS 1996, comenzó a piezas CAD representaciones compañía de base de datos para los diseñadores e ingenieros de ayuda con el proceso de diseño. La compañía ha completado su producto y está empezando a venderlo. El caso examina cuestiones relacionadas con la organización de la fuerza de ventas y el precio del producto.Starting at €8.20
-
Affinity Labs, Inc.
Lassiter, Joseph B.; Kind, LizCase HBS-809019-EEntrepreneurshipIn November 2006, Chris Michel left Military.com, which he founded in 1999, to start Affinity Labs, a global network of online communities. That month, Michel raised a Series A round of venture funding and established a partnership with Monster, which he had sold Military.com to. Within its first year of operations, Affinity Labs launched eight vertical portals including PoliceLink, NursingLink, TechCommunity, and IndiaOn. While the company was w...Starting at €8.20
-
Bloodbuy
Hamermesh, Richard G.; Norris, MichaelCase HBS-815114-EEntrepreneurshipIn 2015, Chris Godfrey, founder and CEO of Bloodbuy has to consider the best path to growth for his young company that is attempting to disrupt the blood donation industry.Starting at €8.20
-
Amylin Pharmaceuticals B
Hamermesh, Richard G.; Knoop, Carin-IsabelCase HBS-813091-EEntrepreneurshipSupplement for case 809011Starting at €8.20
-
Novasys Medical
Hamermesh, Richard G.; Barley, LaurenCase HBS-810027-EEntrepreneurshipNovasys has developed a new medical device and procedure for the treatment of female stress urinary incontinence that is cheaper and can be performed in doctors' offices. In spite of FDA approval, the American Medical Association has been unwilling to approve the product for reimbursement. The case deals with the company's struggle to obtain a reimbursement code.Starting at €8.20
-
Impact Investing for Cancer
Hamermesh, Richard G.; Preble, MatthewCase HBS-818068-EStrategyStarting at €8.20